{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,2]],"date-time":"2026-10-02T00:24:05Z","timestamp":1790900645304,"version":"4.1.0"},"reference-count":53,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2011,1,12]],"date-time":"2011-01-12T00:00:00Z","timestamp":1294790400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Naunyn-Schmied Arch Pharmacol"],"published-print":{"date-parts":[[2011,3]]},"DOI":"10.1007\/s00210-010-0596-4","type":"journal-article","created":{"date-parts":[[2011,1,11]],"date-time":"2011-01-11T07:56:23Z","timestamp":1294732583000},"page":"297-308","source":"Crossref","is-referenced-by-count":68,"title":["Zoledronic acid inhibits RANK expression and migration of osteoclast precursors during osteoclastogenesis"],"prefix":"10.1007","volume":"383","author":[{"given":"Keiichiro","family":"Kimachi","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hiroshi","family":"Kajiya","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shuji","family":"Nakayama","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Tetsuro","family":"Ikebe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Koji","family":"Okabe","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2011,1,12]]},"reference":[{"key":"596_CR1","doi-asserted-by":"crossref","first-page":"1733","DOI":"10.1002\/ijc.23745","volume":"123","author":"KS Ahn","year":"2008","unstructured":"Ahn KS, Sethi G, Chaturvedi MM, Aggarwal BB (2008) Simvastatin, 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibitor, suppresses osteoclastogenesis induced by receptor activator of nuclear factor-kappaB ligand through modulation of NF-kappaB pathway. Int J Cancer 123:1733\u20131740","journal-title":"Int J Cancer"},{"key":"596_CR2","doi-asserted-by":"crossref","first-page":"1657","DOI":"10.1016\/S0022-2275(20)41388-4","volume":"33","author":"D Amin","year":"1992","unstructured":"Amin D, Cornell SA, Gustafson SK, Needle SJ, Ullrich JW, Bilder GE, Perrone MH (1992) Bisphosphonates used for the treatment of bone disorders inhibit squalene synthase and cholesterol biosynthesis. J Lipid Res 33:1657\u20131663","journal-title":"J Lipid Res"},{"key":"596_CR3","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1038\/36593","volume":"390","author":"DM Anderson","year":"1997","unstructured":"Anderson DM, Maraskovsky E, Billingsley WL, Dougall WC, Tometsko ME, Roux ER, Teepe MC, DuBose RF, Cosman D, Galibert L (1997) A homologue of the TNF receptor and its ligand enhance T-cell growth and dendritic-cell function. Nature 390:175\u2013179","journal-title":"Nature"},{"key":"596_CR4","doi-asserted-by":"crossref","first-page":"1416","DOI":"10.1016\/j.bone.2010.01.383","volume":"46","author":"C Boudot","year":"2010","unstructured":"Boudot C, Saidak Z, Boulanouar AK, Petit L, Gouilleux F, Massy Z, Brazier M, Mentaverri R, Kamel S (2010) Implication of the calcium sensing receptor and the Phosphoinositide 3-kinase\/Akt pathway in the extracellular calcium-mediated migration of RAW 264.7 osteoclast precursor cells. Bone 46:1416\u20131423","journal-title":"Bone"},{"key":"596_CR5","doi-asserted-by":"crossref","first-page":"337","DOI":"10.1038\/nature01658","volume":"423","author":"WJ Boyle","year":"2003","unstructured":"Boyle WJ, Simonet WS, Lacey DL (2003) Osteoclast differentiation and activation. Nature 423:337\u2013342","journal-title":"Nature"},{"key":"596_CR6","doi-asserted-by":"crossref","first-page":"149","DOI":"10.1002\/path.2287","volume":"214","author":"JR Bradley","year":"2008","unstructured":"Bradley JR (2008) TNF-mediated inflammatory disease. J Pathol 214:149\u2013160","journal-title":"J Pathol"},{"key":"596_CR7","doi-asserted-by":"crossref","first-page":"301","DOI":"10.2174\/1389450053765833","volume":"6","author":"M Caraglia","year":"2005","unstructured":"Caraglia M, Budillon A, Tagliaferri P, Marra M, Abbruzzese A, Caponigro F (2005) Isoprenylation of intracellular proteins as a new target for the therapy of human neoplasms: preclinical and clinical implications. Curr Drug Targets 6:301\u2013323","journal-title":"Curr Drug Targets"},{"key":"596_CR8","doi-asserted-by":"crossref","first-page":"161","DOI":"10.1042\/bst0230161","volume":"23","author":"PJ Casey","year":"1995","unstructured":"Casey PJ (1995) Mechanisms of protein prenylation and role in G protein function. Biochem Soc Trans 23:161\u2013166","journal-title":"Biochem Soc Trans"},{"key":"596_CR9","doi-asserted-by":"crossref","first-page":"828","DOI":"10.1016\/j.bone.2006.11.023","volume":"40","author":"C Dannemann","year":"2007","unstructured":"Dannemann C, Gr\u00e4tz KW, Riener MO, Zwahlen RA (2007) Jaw osteonecrosis related to bisphosphonate therapy: a severe secondary disorder. Bone 40:828\u2013834","journal-title":"Bone"},{"key":"596_CR10","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1056\/NEJM199702203360807","volume":"336","author":"PD Delmas","year":"1997","unstructured":"Delmas PD, Meunier PJ (1997) The management of Paget's disease of bone. N Engl J Med 336:558\u2013566","journal-title":"N Engl J Med"},{"key":"596_CR11","doi-asserted-by":"crossref","first-page":"133","DOI":"10.1073\/pnas.96.1.133","volume":"96","author":"JE Fisher","year":"1999","unstructured":"Fisher JE, Rogers MJ, Halasy JM, Luckman SP, Hughes DE, Masarachia PJ, Wesolowski G, Russell RG, Rodan GA, Reszka AA (1999) Alendronate mechanism of action: geranylgeraniol, an intermediate in the mevalonate pathway, prevents inhibition of osteoclast formation, bone resorption, and kinase activation in vitro. Proc Natl Acad Sci USA 96:133\u2013138","journal-title":"Proc Natl Acad Sci USA"},{"key":"596_CR12","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1055\/s-2007-979008","volume":"29","author":"H Fleisher","year":"1997","unstructured":"Fleisher H (1997) Bisphosphonates: mechanisms of action and clinical use in osteoporosis\u2013an update. Horm Metab Res 29:145\u2013150","journal-title":"Horm Metab Res"},{"key":"596_CR13","first-page":"6538","volume":"62","author":"P Fourier","year":"2002","unstructured":"Fourier P, Boissier S, Filleur S, Guglielmi J, Cabon F, Colombel M, Clezardin P (2002) Bisphosphonates inhibit angiogenesis in vitro and testosterone-stimulated vascular regrowth in the ventral prostate in castrated rats. Cancer Res 62:6538\u20136544","journal-title":"Cancer Res"},{"key":"596_CR14","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1007\/BF03345497","volume":"25","author":"O Fromigu\u00e9","year":"2002","unstructured":"Fromigu\u00e9 O, Body JJ (2002) Bisphosphonates influence the proliferation and the maturation of normal human osteoblasts. J Endocrinol Investig 25:539\u2013546","journal-title":"J Endocrinol Investig"},{"key":"596_CR15","doi-asserted-by":"crossref","first-page":"34120","DOI":"10.1074\/jbc.273.51.34120","volume":"273","author":"L Galibert","year":"1998","unstructured":"Galibert L, Tometsko ME, Anderson DM, Cosman D, Dougall WC (1998) The involvement of multiple tumor necrosis factor receptor (TNFR)-associated factors in the signaling mechanisms of receptor activator of NF-kappaB, a member of the TNFR superfamily. J Biol Chem 273:34120\u201334127","journal-title":"J Biol Chem"},{"key":"596_CR16","doi-asserted-by":"crossref","first-page":"175","DOI":"10.1016\/0092-8674(94)90308-5","volume":"77","author":"JB Gibbs","year":"1994","unstructured":"Gibbs JB, Oliff A, Kohl NE (1994) Farnesyltransferase inhibitors: Ras research yields a potential cancer therapeutic. Cell 77:175\u2013178","journal-title":"Cell"},{"key":"596_CR17","doi-asserted-by":"crossref","unstructured":"Hasmim M, Bieler G, R\u00fcegg C (2007) Zoledronate inhibits endothelial cell adhesion, migration and survival throught the suppression of multiple, prenylation-dependent signaling pathways. J Thromb Haemost 5:166\u2013173","DOI":"10.1111\/j.1538-7836.2006.02259.x"},{"key":"596_CR18","doi-asserted-by":"crossref","first-page":"127","DOI":"10.1016\/j.placenta.2005.02.012","volume":"27","author":"AV Huber","year":"2006","unstructured":"Huber AV, Saleh L, Bauer S, Husslein P, Kn\u00f6fler M (2006) TNF alpha-mediated induction of PAI-1 restricts invasion of HTR-8\/SVneo trophoblast cells. Placenta 27:127\u2013136","journal-title":"Placenta"},{"key":"596_CR19","doi-asserted-by":"crossref","first-page":"1478","DOI":"10.1002\/jbmr.5650101008","volume":"10","author":"DE Hughes","year":"1995","unstructured":"Hughes DE, Wright KR, Uy HL, Sasaki A, Yoneda T, Roodman GD, Mundy GR, Boyce BF (1995) Bisphosphonates promote apoptosis in murine osteoclasts in vitro and in vivo. J Bone Miner Res 10:1478\u20131487","journal-title":"J Bone Miner Res"},{"key":"596_CR20","doi-asserted-by":"crossref","first-page":"578","DOI":"10.1002\/(SICI)1097-0215(19980812)77:4<578::AID-IJC18>3.0.CO;2-2","volume":"77","author":"T Ikebe","year":"1998","unstructured":"Ikebe T, Takeuchi H, Jimi E, Beppu M, Shinohara M, Shirasuna K (1998) Involvement of proteasomes in migration and matrix metalloproteinase-9 production of oral squamous cell carcinoma. Int J Cancer 77:578\u2013585","journal-title":"Int J Cancer"},{"key":"596_CR21","doi-asserted-by":"crossref","first-page":"1942","DOI":"10.1172\/JCI1039","volume":"101","author":"RL Jilka","year":"1998","unstructured":"Jilka RL, Takahashi K, Munshi M, Williams DC, Roberson PK, Manolagas SC (1998) Loss of estrogen upregulates osteoblastogenesis in the murine bone marrow. Evidence for autonomy from factors released during bone resorption. J Clin Invest 101:1942\u20131950","journal-title":"J Clin Invest"},{"key":"596_CR22","doi-asserted-by":"crossref","first-page":"11454","DOI":"10.1074\/jbc.M805933200","volume":"284","author":"E Kakiashvili","year":"2009","unstructured":"Kakiashvili E, Speight P, Waheed F, Seth R, Lodyga M, Tanimura S, Kohno M, Rotstein OD, Kapus A, Sz\u00e1szi K (2009) GEF-H1 mediates tumor necrosis factor-alpha-induced Rho activation and myosin phosphorylation: role in the regulation of tubular paracellular permeability. J Biol Chem 284:11454\u20131166","journal-title":"J Biol Chem"},{"key":"596_CR23","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1038\/emm.2002.21","volume":"34","author":"YH Kim","year":"2002","unstructured":"Kim YH, Kim GS, Jeong-Hwa B (2002) Inhibitory action of bisphosphonates on bone resorption does not involve the regulation of RANKL and OPG expression. Exp Mol Med 34:145\u2013151","journal-title":"Exp Mol Med"},{"key":"596_CR24","doi-asserted-by":"crossref","first-page":"1193","DOI":"10.1248\/bpb.32.1193","volume":"32","author":"HB Kwak","year":"2009","unstructured":"Kwak HB, Kim JY, Kim KJ, Choi MK, Kim JJ, Kim KM, Shin YI, Lee MS, Kim HS, Kim JW, Chun CH, Cho HJ, Hong GY, Juhng SK, Yoon KH, Park BH, Bae JM, Han JK, Oh J (2009) Risedronate directly inhibits osteoclast differentiation and inflammatory bone loss. Biol Pharm Bull 32:1193\u20131198","journal-title":"Biol Pharm Bull"},{"key":"596_CR25","doi-asserted-by":"crossref","first-page":"843","DOI":"10.1016\/j.bone.2009.07.011","volume":"45","author":"P Lesclous","year":"2009","unstructured":"Lesclous P, Abi Najm S, Carrel JP, Baroukh B, Lombardi T, Willi JP, Rizzoli R, Saffar JL, Samson J (2009) Bisphosphonate-associated osteonecrosis of the jaw: a key role of inflammation? Bone 45:843\u2013852","journal-title":"Bone"},{"key":"596_CR26","doi-asserted-by":"crossref","first-page":"1566","DOI":"10.1073\/pnas.97.4.1566","volume":"97","author":"J Li","year":"2000","unstructured":"Li J, Sarosi I, Yan XQ, Morony S, Capparelli C, Tan HL, McCabe S, Elliott R, Scully S, Van G, Kaufman S, Juan SC, Sun Y, Tarpley J, Martin L, Christensen K, McCabe J, Kostenuik P, Hsu H, Fletcher F, Dunstan CR, Lacey DL, Boyle WJ (2000) RANK is the intrinsic hematopoietic cell surface receptor that controls osteoclastogenesis and regulation of bone mass and calcium metabolism. Proc Natl Acad Sci USA 97:1566\u20131571","journal-title":"Proc Natl Acad Sci USA"},{"key":"596_CR27","doi-asserted-by":"crossref","first-page":"203","DOI":"10.1016\/j.orthres.2004.06.018","volume":"23","author":"TS Liao","year":"2005","unstructured":"Liao TS, Yurgelun MB, Chang SS, Zhang HZ, Murakami K, Blaine TA, Parisien MV, Kim W, Winchester RJ, Lee FY (2005) Recruitment of osteoclast precursors by stromal cell derived factor-1 (SDF-1) in giant cell tumor of bone. J Orthop Res 23:203\u2013209","journal-title":"J Orthop Res"},{"key":"596_CR28","doi-asserted-by":"crossref","first-page":"1437","DOI":"10.1056\/NEJM199511303332201","volume":"333","author":"UA Liberman","year":"1995","unstructured":"Liberman UA, Weiss SR, Br\u00f6ll J, Minne HW, Quan H, Bell NH, Rodriguez-Portales J, Downs RW Jr, Dequeker J, Favus M (1995) Effect of oral alendronate on bone mineral density and the incidence of fractures in postmenopausal osteoporosis. N Engl J Med 333:1437\u20131443","journal-title":"N Engl J Med"},{"key":"596_CR29","doi-asserted-by":"crossref","first-page":"581","DOI":"10.1359\/jbmr.1998.13.4.581","volume":"13","author":"SP Luckman","year":"1998","unstructured":"Luckman SP, Hughes DE, Coxon FP, Graham R, Russell G, Rogers MJ (1998) Nitrogen-containing bisphosphonates inhibit the mevalonate pathway and prevent post-translational prenylation of GTP-binding proteins, including Ras. J Bone Miner Res 13:581\u2013589","journal-title":"J Bone Miner Res"},{"key":"596_CR30","doi-asserted-by":"crossref","first-page":"1768","DOI":"10.1359\/jbmr.1999.14.10.1768","volume":"14","author":"MC Monier-Faugere","year":"1999","unstructured":"Monier-Faugere MC, Geng Z, Paschalis EP, Qi Q, Arnala I, Bauss F, Boskey AL (1999) Intermittent and continuous administration of the bisphosphonate ibandronate in overiohysterectomized beagle dogs effects on bone morphometry and mineral properties. J Bone Miner Res 14:1768\u20131778","journal-title":"J Bone Miner Res"},{"key":"596_CR31","doi-asserted-by":"crossref","first-page":"9","DOI":"10.1016\/8756-3282(95)00426-2","volume":"18","author":"M Nishikawa","year":"1996","unstructured":"Nishikawa M, Akatsu T, Katayama Y, Yasutomo Y, Kado S, Kugal N, Yamamoto M, Nagata N (1996) Bisphosphonates act on osteoblastic cells and inhibit osteoclast formation in mouse marrow cultures. Bone 18:9\u201314","journal-title":"Bone"},{"key":"596_CR32","doi-asserted-by":"crossref","first-page":"150","DOI":"10.1002\/jbmr.5650110203","volume":"11","author":"AM Parfitt","year":"1996","unstructured":"Parfitt AM, Mundy GR, Roodman GD, Hughes DE, Boyce BF (1996) A new model for the regulation of bone resorption, with particular reference to the effects of bisphosphonates. J Bone Miner Res 11:150\u2013159","journal-title":"J Bone Miner Res"},{"key":"596_CR33","doi-asserted-by":"crossref","first-page":"507","DOI":"10.1016\/j.cardiores.2004.07.020","volume":"64","author":"KE Porter","year":"2004","unstructured":"Porter KE, Turner NA, O'Regan DJ, Ball SG (2004) Tumor necrosis factor alpha induces human atrial myofibroblast proliferation, invasion and MMP-9 secretion: inhibition by simvastatin. Cardiovasc Res 64:507\u2013515","journal-title":"Cardiovasc Res"},{"key":"596_CR34","doi-asserted-by":"crossref","first-page":"401","DOI":"10.1016\/0092-8674(92)90164-8","volume":"70","author":"AJ Ridley","year":"1992","unstructured":"Ridley AJ, Paterson HF, Johnston CL, Diekmann D, Hall A (1992) The small GTP-binding protein rac regulates growth factor-induced membrane ruffling. Cell 70:401\u2013410","journal-title":"Cell"},{"key":"596_CR35","doi-asserted-by":"crossref","first-page":"606","DOI":"10.1359\/jbmr.091009","volume":"25","author":"AJ Roelofs","year":"2010","unstructured":"Roelofs AJ, Coxon FO, Ebetino FH, Lundy MW, Henneman ZJ, Nancollas GH, Sun S, Blazewska KM, Bala JL, Kashemirov BA, Khalid AB, Mckenna CE, Rogers MJ (2010) Fluorescent risedronate analogue reveal bisphosphonate uptake by bone marrow monocytes and localization around osteocytes in vivo. J Bone Miner Res 25:606\u2013616","journal-title":"J Bone Miner Res"},{"key":"596_CR36","doi-asserted-by":"crossref","first-page":"2643","DOI":"10.2174\/1381612033453640","volume":"9","author":"MJ Rogers","year":"2003","unstructured":"Rogers MJ (2003) New insights into the molecular mechanisms of action of bisphosphonates. Curr Pharm Des 9:2643\u20132658","journal-title":"Curr Pharm Des"},{"key":"596_CR37","doi-asserted-by":"crossref","first-page":"2961","DOI":"10.1002\/1097-0142(20000615)88:12+<2961::AID-CNCR12>3.0.CO;2-L","volume":"88","author":"MJ Rogers","year":"2000","unstructured":"Rogers MJ, Gordon S, Benford HL, Coxon FP, Luckman SP, Monkkonen J, Frith JC (2000) Cellular and molecular mechanisms of action of bisphosphonates. Cancer 88:2961\u20132978","journal-title":"Cancer"},{"key":"596_CR38","doi-asserted-by":"crossref","first-page":"209","DOI":"10.1016\/8756-3282(96)00211-6","volume":"9","author":"GD Roodman","year":"1996","unstructured":"Roodman GD (1996) Paget's disease and osteoclast biology. Bone 9:209\u2013212","journal-title":"Bone"},{"key":"596_CR39","doi-asserted-by":"crossref","first-page":"2004","DOI":"10.1172\/JCI116422","volume":"91","author":"M Sahni","year":"1993","unstructured":"Sahni M, Guenther HL, Fleisch H, Collin P, Martin TJ (1993) Bisphosphonates act on rat bone resorption through the mediation of osteoblasts. J Clin Invest 91:2004\u20132011","journal-title":"J Clin Invest"},{"key":"596_CR40","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1006\/excr.2000.5049","volume":"261","author":"AA Schmitz","year":"2000","unstructured":"Schmitz AA, Govek EE, B\u00f6ttner B, Van Aelst L (2000) Rho GTPases: signaling, migration, and invasion. Exp Cell Res 261:1\u201312","journal-title":"Exp Cell Res"},{"key":"596_CR41","first-page":"251","volume":"84","author":"MC Seabra","year":"1998","unstructured":"Seabra MC, James GL (1998) Prenylation assays for small GTPases. Methods Mol Biol 84:251\u2013260","journal-title":"Methods Mol Biol"},{"key":"596_CR42","doi-asserted-by":"crossref","first-page":"345","DOI":"10.1210\/er.20.3.345","volume":"20","author":"T Suda","year":"1999","unstructured":"Suda T, Takahashi N, Udagawa N, Jimi E, Gillespie MT, Martin TJ (1999) Modulation of osteoclast differentiation and function by the new members of the tumor necrosis factor receptor and ligand families. Endocr Rev 20:345\u2013357","journal-title":"Endocr Rev"},{"key":"596_CR43","doi-asserted-by":"crossref","first-page":"93","DOI":"10.1007\/978-0-387-72009-8_12","volume":"602","author":"H Takayanagi","year":"2007","unstructured":"Takayanagi H (2007) Novel signaling pathways and therapeutic targets in osteoclasts. Adv Exp Med Biol 602:93\u201396","journal-title":"Adv Exp Med Biol"},{"key":"596_CR44","doi-asserted-by":"crossref","first-page":"889","DOI":"10.1016\/S1534-5807(02)00369-6","volume":"3","author":"H Takayanagi","year":"2002","unstructured":"Takayanagi H, Kim S, Koga T, Nishina H, Isshiki M, Yoshida H, Saiura A, Isobe M, Yokochu T, Inoue J, Wagner EF, Mark TW, Kodama T, Taniguchi T (2002) Induction and activation of the transcription factor NFATc1 (NFAT2) integrate RANKL signaling in terminal differentiation of osteoclasts. Dev Cell 3:889\u2013901","journal-title":"Dev Cell"},{"key":"596_CR45","doi-asserted-by":"crossref","first-page":"638","DOI":"10.1038\/nrg1122","volume":"4","author":"SL Teitelbaum","year":"2003","unstructured":"Teitelbaum SL, Ross FP (2003) Genetic regulation of osteoclast development and function. Nat Rev Genet 4:638\u2013649","journal-title":"Nat Rev Genet"},{"key":"596_CR46","doi-asserted-by":"crossref","first-page":"558","DOI":"10.1111\/j.1600-0463.2009.02518.x","volume":"117","author":"AM Tloczek","year":"2009","unstructured":"Tloczek AM, Blaszczyk-Brzezinska E (2009) IL-6, but not IL-4, stimulates chemokinesis and TNF stimulates chemotaxis of tissue mast cells: involvement of both mitogen-activated protein kinases and phosphatidylinositol 3-kinase signaling pathways. APMIS 117:558\u2013567","journal-title":"APMIS"},{"key":"596_CR47","doi-asserted-by":"crossref","first-page":"168","DOI":"10.1016\/j.yjmcc.2007.05.006","volume":"43","author":"NA Turner","year":"2007","unstructured":"Turner NA, Aley PK, Hall KT, Warburton P, Galloway S, Midgley L, O'Regan DJ, Wood IC, Ball SG, Porter KE (2007) Simvastatin inhibits TNFalpha-induced invasion of human cardiac myofibroblasts via both MMP-9-dependent and -independent mechanisms. J Mol Cell Cardiol 43:168\u2013176","journal-title":"J Mol Cell Cardiol"},{"key":"596_CR48","doi-asserted-by":"crossref","first-page":"1055","DOI":"10.1124\/jpet.102.035295","volume":"302","author":"J Wood","year":"2002","unstructured":"Wood J, Bonjean K, Ruetz S, Bellahc\u00e8ne A, Devy L, Foidart JM, Castronovo V, Green JR (2002) Novel antiangiogenic effects of the bisphosphonate compound zoledronic acid. J Pharmacol Exp Ther 302:1055\u20131061","journal-title":"J Pharmacol Exp Ther"},{"key":"596_CR49","doi-asserted-by":"crossref","first-page":"11846","DOI":"10.1074\/jbc.M512624200","volume":"281","author":"Z Yao","year":"2006","unstructured":"Yao Z, Li P, Zhang Q, Schwarz E, Keng P, Arbini A, Boyce AB, Xing L (2006) Tumor necrosis factor-alpha increases circulating osteoclast precursor numbers by promoting their proliferation and differentiation in the bone marrow through up-regulation of c-fms expression. J Biol Chem 281:11846\u201311855","journal-title":"J Biol Chem"},{"key":"596_CR50","doi-asserted-by":"crossref","first-page":"241","DOI":"10.1146\/annurev.bi.65.070196.001325","volume":"65","author":"FL Zhang","year":"1996","unstructured":"Zhang FL, Casey PJ (1996) Protein prenylation: molecular mechanisms and functional consequences. Annu Rev Biochem 65:241\u2013269","journal-title":"Annu Rev Biochem"},{"key":"596_CR51","doi-asserted-by":"crossref","first-page":"864","DOI":"10.1016\/S0026-895X(25)09387-3","volume":"50","author":"C Zhang","year":"1996","unstructured":"Zhang C, Schmidt M, von Eichei-Streiber C, Jakobs KH (1996) Inhibition by toxin B of inositol phosphate formation induced by G protein-coupled and tyrosine kinase receptors in N1E-115 neuroblastoma cells: involvement of Rho proteins. Mol Pharmacol 50:864\u2013869","journal-title":"Mol Pharmacol"},{"key":"596_CR52","doi-asserted-by":"crossref","first-page":"563","DOI":"10.1074\/jbc.M008198200","volume":"276","author":"YH Zhang","year":"2001","unstructured":"Zhang YH, Heulsmann A, Tondravi MM, Mukherjee A, Abu-Amer Y (2001) Tumor necrosis factor-alpha (TNF) stimulates RANKL-induced osteoclastogenesis via coupling of TNF type 1 receptor and RANK signaling pathways. J Biol Chem 276:563\u2013568","journal-title":"J Biol Chem"},{"key":"596_CR53","doi-asserted-by":"crossref","first-page":"R37","DOI":"10.1186\/ar2391","volume":"10","author":"Q Zhang","year":"2008","unstructured":"Zhang Q, Guo R, Schwarz EM, Boyce BF, Xing L (2008) TNF inhibits production of stromal cell-derived factor 1 by bone stromal cells and increases osteoclast precursor mobilization from bone marrow to peripheral blood. Arthritis Res Ther 10:R37","journal-title":"Arthritis Res Ther"}],"container-title":["Naunyn-Schmiedeberg's Archives of Pharmacology"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0596-4.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s00210-010-0596-4\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s00210-010-0596-4","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T15:59:17Z","timestamp":1740844757000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s00210-010-0596-4"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2011,1,12]]},"references-count":53,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2011,3]]}},"alternative-id":["596"],"URL":"https:\/\/doi.org\/10.1007\/s00210-010-0596-4","relation":{},"ISSN":["0028-1298","1432-1912"],"issn-type":[{"value":"0028-1298","type":"print"},{"value":"1432-1912","type":"electronic"}],"subject":[],"published":{"date-parts":[[2011,1,12]]}}}